| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 7 | 357 | 177 | - | - | - | 541 |
| - | - | - | - | - | 66 | 58 | - | - | - | 124 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 5 |
| 2 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 39 |
| 175 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 541 | 92.0% | -2.13 | 124 | 40.9% |
| PLP(R) | 34 | 5.8% | 2.12 | 148 | 48.8% |
| SLP(R) | 1 | 0.2% | 4.46 | 22 | 7.3% |
| CentralBrain-unspecified | 4 | 0.7% | 0.32 | 5 | 1.7% |
| AME(R) | 5 | 0.9% | -1.32 | 2 | 0.7% |
| Optic-unspecified(R) | 3 | 0.5% | -0.58 | 2 | 0.7% |
| upstream partner | # | NT | conns MeVP31 | % In | CV |
|---|---|---|---|---|---|
| MeTu3b (R) | 22 | ACh | 140 | 24.7% | 0.8 |
| Dm-DRA1 (R) | 19 | Glu | 87 | 15.3% | 0.8 |
| Cm18 (R) | 9 | Glu | 79 | 13.9% | 0.5 |
| R7d | 13 | HA | 37 | 6.5% | 0.7 |
| aMe17e (R) | 1 | Glu | 20 | 3.5% | 0.0 |
| MeVPMe10 (L) | 2 | Glu | 19 | 3.4% | 0.7 |
| Tm34 (R) | 6 | Glu | 16 | 2.8% | 0.8 |
| MeVP15 (R) | 7 | ACh | 14 | 2.5% | 0.5 |
| Mi15 (R) | 12 | ACh | 13 | 2.3% | 0.3 |
| CB0670 (R) | 1 | ACh | 10 | 1.8% | 0.0 |
| Cm22 (R) | 3 | GABA | 9 | 1.6% | 0.5 |
| MeTu3a (R) | 7 | ACh | 9 | 1.6% | 0.4 |
| Tm5c (R) | 7 | Glu | 8 | 1.4% | 0.3 |
| MeVC2 (L) | 1 | ACh | 7 | 1.2% | 0.0 |
| MeLo5 (R) | 3 | ACh | 7 | 1.2% | 0.5 |
| Cm10 (R) | 3 | GABA | 6 | 1.1% | 0.4 |
| MeTu1 (R) | 4 | ACh | 6 | 1.1% | 0.3 |
| MeLo3b (R) | 3 | ACh | 5 | 0.9% | 0.3 |
| MeTu3c (R) | 5 | ACh | 5 | 0.9% | 0.0 |
| MeTu2a (R) | 4 | ACh | 4 | 0.7% | 0.0 |
| Cm23 (R) | 4 | Glu | 4 | 0.7% | 0.0 |
| MeVP22 (R) | 1 | GABA | 3 | 0.5% | 0.0 |
| Dm2 (R) | 3 | ACh | 3 | 0.5% | 0.0 |
| Cm21 (R) | 3 | GABA | 3 | 0.5% | 0.0 |
| aMe5 (R) | 3 | ACh | 3 | 0.5% | 0.0 |
| Dm9 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| SLP267 (R) | 1 | Glu | 2 | 0.4% | 0.0 |
| R7y | 1 | HA | 2 | 0.4% | 0.0 |
| aMe6b (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| aMe12 (R) | 1 | ACh | 2 | 0.4% | 0.0 |
| SLP004 (R) | 1 | GABA | 2 | 0.4% | 0.0 |
| Cm4 (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| MeVC27 (L) | 2 | unc | 2 | 0.4% | 0.0 |
| MeVP12 (R) | 2 | ACh | 2 | 0.4% | 0.0 |
| Cm17 (R) | 2 | GABA | 2 | 0.4% | 0.0 |
| Cm-DRA (R) | 2 | ACh | 2 | 0.4% | 0.0 |
| Cm28 (R) | 2 | Glu | 2 | 0.4% | 0.0 |
| Tm5a (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm3 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm7 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| AOTU058 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm8 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeVP14 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| SLP460 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm11d (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Lat1 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| Cm14 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| aMe10 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Lat2 (R) | 1 | unc | 1 | 0.2% | 0.0 |
| PLP080 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP59 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| 5-HTPMPV01 (L) | 1 | 5-HT | 1 | 0.2% | 0.0 |
| MeVC20 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP45 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm33 (R) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeVC8 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| PLP177 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 1 | 0.2% | 0.0 |
| MeVP56 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVC21 (R) | 1 | Glu | 1 | 0.2% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 1 | 0.2% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.2% | 0.0 |
| mALD1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| downstream partner | # | NT | conns MeVP31 | % Out | CV |
|---|---|---|---|---|---|
| Cm22 (R) | 9 | GABA | 93 | 12.9% | 0.6 |
| FB8B (R) | 2 | Glu | 51 | 7.1% | 0.1 |
| Cm21 (R) | 9 | GABA | 38 | 5.3% | 0.7 |
| AOTU056 (R) | 3 | GABA | 30 | 4.2% | 0.8 |
| MeVP38 (R) | 1 | ACh | 27 | 3.8% | 0.0 |
| CB0937 (R) | 3 | Glu | 26 | 3.6% | 0.1 |
| MeVPaMe2 (R) | 1 | Glu | 22 | 3.1% | 0.0 |
| PLP231 (R) | 2 | ACh | 21 | 2.9% | 0.1 |
| CB4127 (R) | 1 | unc | 20 | 2.8% | 0.0 |
| CL234 (R) | 2 | Glu | 20 | 2.8% | 0.4 |
| Tm5c (R) | 13 | Glu | 20 | 2.8% | 0.5 |
| Cm18 (R) | 7 | Glu | 18 | 2.5% | 0.4 |
| Cm12 (R) | 12 | GABA | 17 | 2.4% | 0.5 |
| MeVP12 (R) | 8 | ACh | 16 | 2.2% | 0.9 |
| SLP295 (R) | 2 | Glu | 14 | 1.9% | 0.9 |
| aMe4 (R) | 5 | ACh | 14 | 1.9% | 0.8 |
| aMe23 (R) | 1 | Glu | 13 | 1.8% | 0.0 |
| Cm8 (R) | 8 | GABA | 13 | 1.8% | 0.4 |
| DNpe035 (R) | 1 | ACh | 9 | 1.2% | 0.0 |
| aMe15 (R) | 1 | ACh | 9 | 1.2% | 0.0 |
| Cm3 (R) | 6 | GABA | 9 | 1.2% | 0.3 |
| CL086_d (R) | 1 | ACh | 8 | 1.1% | 0.0 |
| aMe24 (R) | 1 | Glu | 8 | 1.1% | 0.0 |
| aMe5 (R) | 4 | ACh | 8 | 1.1% | 0.6 |
| MeLo5 (R) | 5 | ACh | 8 | 1.1% | 0.5 |
| SLP064 (R) | 1 | Glu | 6 | 0.8% | 0.0 |
| SLP074 (R) | 1 | ACh | 6 | 0.8% | 0.0 |
| CL075_a (R) | 1 | ACh | 6 | 0.8% | 0.0 |
| PLP080 (R) | 1 | Glu | 6 | 0.8% | 0.0 |
| aMe17b (R) | 2 | GABA | 6 | 0.8% | 0.7 |
| Tm35 (R) | 6 | Glu | 6 | 0.8% | 0.0 |
| SMP528 (R) | 1 | Glu | 5 | 0.7% | 0.0 |
| CL086_a (R) | 1 | ACh | 5 | 0.7% | 0.0 |
| DNp27 (R) | 1 | ACh | 5 | 0.7% | 0.0 |
| CB3118 (R) | 2 | Glu | 5 | 0.7% | 0.6 |
| MeVP15 (R) | 3 | ACh | 5 | 0.7% | 0.6 |
| s-LNv (R) | 2 | ACh | 5 | 0.7% | 0.2 |
| CL365 (R) | 2 | unc | 5 | 0.7% | 0.2 |
| Cm10 (R) | 4 | GABA | 5 | 0.7% | 0.3 |
| Cm14 (R) | 4 | GABA | 5 | 0.7% | 0.3 |
| MeVP6 (R) | 5 | Glu | 5 | 0.7% | 0.0 |
| CL014 (R) | 1 | Glu | 4 | 0.6% | 0.0 |
| DN1pA (R) | 1 | Glu | 4 | 0.6% | 0.0 |
| Tm34 (R) | 3 | Glu | 4 | 0.6% | 0.4 |
| Cm16 (R) | 3 | Glu | 4 | 0.6% | 0.4 |
| OLVC4 (L) | 1 | unc | 3 | 0.4% | 0.0 |
| CB3249 (R) | 1 | Glu | 3 | 0.4% | 0.0 |
| aMe1 (R) | 1 | GABA | 3 | 0.4% | 0.0 |
| OLVC4 (R) | 1 | unc | 3 | 0.4% | 0.0 |
| MeTu3a (R) | 3 | ACh | 3 | 0.4% | 0.0 |
| Cm5 (R) | 1 | GABA | 2 | 0.3% | 0.0 |
| SLP366 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| CL073 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| Lat2 (R) | 1 | unc | 2 | 0.3% | 0.0 |
| LoVP60 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| LoVP65 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| PLP094 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| SMP331 (R) | 1 | ACh | 2 | 0.3% | 0.0 |
| Cm6 (R) | 2 | GABA | 2 | 0.3% | 0.0 |
| MeTu2b (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| MeTu3c (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| MeLo3b (R) | 2 | ACh | 2 | 0.3% | 0.0 |
| DN1pB (R) | 2 | Glu | 2 | 0.3% | 0.0 |
| Pm12 (R) | 2 | GABA | 2 | 0.3% | 0.0 |
| SMP467 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC27 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| Mi17 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm4 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Tm12 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Mi9 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP267 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm20 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL086_b (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV6f5 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| AOTU058 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeTu2a (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP175 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2269 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeTu1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeTu4c (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm37 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3360 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3508 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP14 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB1059 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB3603 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP364 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP82 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD1b1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| DNpe053 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SIP031 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe8 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| SLP360_a (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP74 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| WED092 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe13 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP250 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe30 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe12 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP96 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP57 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC21 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVC19 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP49 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP100 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm35 (R) | 1 | GABA | 1 | 0.1% | 0.0 |